Before it's here, it's on the Bloomberg Terminal.Learn More
ANU:GR
XORTX Therapeutics Inc
Ticker Change
ANU:GR has changed to a new ticker symbol
No pricing data is available for this time frame
No pricing data is available for this time frame
Before it's here, it's on the Bloomberg Terminal.Learn More
Key Statistics
P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding--
Price to Book Ratio--
Price to Sales Ratio--
1 Year Return--
30 Day Avg Volume--
EPS--
Bloomberg (BEst) EPS Curr Yr--
Dividend--
Last Dividend Reported--
About XORTX Therapeutics Inc
XORTX Therapeutics Inc. focuses on development of drug therapies for metabolic and cardiovascular disease. The Company engages in treatment of kidney disease due to diabetes, as well as develops therapies for health consequences that accompany pre-diabetes, diabetes, and cardiovascular disease. XORTX Therapeutics serves patients in Canada.Address
745 Thurlow Street
Suite 2400
Vancouver, BC V6E 0C5
Canada